October 9, 2020 07:38 AM EDTUpdated 11:50 AM
Coronavirus

Covid-19 roundup: Chi­na joins vac­cine dis­tri­b­u­tion pro­gram re­ject­ed by Trump; Take­da and CSL-led al­liance be­gins blood plas­ma tri­al 

Nicole DeFeudis

Editor

Chi­na has of­fi­cial­ly joined CO­V­AX, the pro­gram set up by CEPI, the WHO, and Gavi to eq­ui­tably dis­trib­ute vac­cines around the world, which the Trump …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Out­look's shares crash as wet AMD drug flunks Phase 3 test

A service from the Financial Times